130 related articles for article (PubMed ID: 2302782)
1. Cross-reactivity of monomeric and dimeric biosynthetic human growth hormone in commercial immunoassays.
Bowsher RR; Apathy JM; Ferguson AL; Riggin RM; Henry DP
Clin Chem; 1990 Feb; 36(2):362-6. PubMed ID: 2302782
[TBL] [Abstract][Full Text] [Related]
2. Variability in the quantitation of circulating growth hormone using commercial immunoassays.
Celniker AC; Chen AB; Wert RM; Sherman BM
J Clin Endocrinol Metab; 1989 Feb; 68(2):469-76. PubMed ID: 2918055
[TBL] [Abstract][Full Text] [Related]
3. Standardization with synthetic 22-kDa monomer human growth hormone reduces discrepancies between two monoclonal immunoradiometric assay kits.
Banfi G; Marinelli M; Pontillo M; Bonini P
Clin Chem; 1992 Oct; 38(10):2107-10. PubMed ID: 1395000
[TBL] [Abstract][Full Text] [Related]
4. Comparison of RIA kits with polyclonal antiserum and IRMA kits with monoclonal antibodies for the determination of plasma prolactin and somatotropin in patients with pituitary adenoma.
Oosterom R; Lamberts SW
J Clin Chem Clin Biochem; 1985 Jan; 23(1):51-4. PubMed ID: 3981090
[TBL] [Abstract][Full Text] [Related]
5. Assay of growth hormone levels in human plasma using commercial kits: analysis of some factors influencing the results.
Chatelain P; Bouillat B; Cohen R; Sassolas G; Souberbielle JC; Ruitton A; Joly MO; Job JC
Acta Paediatr Scand Suppl; 1990; 370():56-61; discussion 62. PubMed ID: 2260459
[TBL] [Abstract][Full Text] [Related]
6. Influence of matrix on concentrations of somatotropin measured in serum with commercial immunoradiometric assays.
Felder RA; Holl RW; Martha P; Bauler G; Hellman P; Wills MR; Thorner MO
Clin Chem; 1989 Jul; 35(7):1423-6. PubMed ID: 2758587
[TBL] [Abstract][Full Text] [Related]
7. Effects of growth hormone-binding proteins on serum growth hormone measurements.
Jan T; Shaw MA; Baumann G
J Clin Endocrinol Metab; 1991 Feb; 72(2):387-91. PubMed ID: 1991809
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a polyclonal and monoclonal immunoassay for PSA: need for an international antigen standard.
Graves HC; Wehner N; Stamey TA
J Urol; 1990 Dec; 144(6):1516-22. PubMed ID: 1700161
[TBL] [Abstract][Full Text] [Related]
9. A nationwide attempt to standardize growth hormone assays.
Tanaka T; Tachibana K; Shimatsu A; Katsumata N; Tsushima T; Hizuka N; Fujieda K; Yokoya S; Irie M
Horm Res; 2005; 64 Suppl 2():6-11. PubMed ID: 16286763
[TBL] [Abstract][Full Text] [Related]
10. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
Arosio M; Nissim M; Ballabio M; Orefice R; Bazzoni N; Faglia G
Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
[TBL] [Abstract][Full Text] [Related]
11. Testicular cancer secretes intact human choriogonadotropin (hCG) and its free beta-subunit: evidence that hCG (+hCG-beta) assays are the most reliable in diagnosis and follow-up.
Saller B; Clara R; Spöttl G; Siddle K; Mann K
Clin Chem; 1990 Feb; 36(2):234-9. PubMed ID: 1689221
[TBL] [Abstract][Full Text] [Related]
12. Somatotropin as measured by a two-site time-resolved immunofluorometric assay.
Strasburger C; Barnard G; Toldo L; Zarmi B; Zadik Z; Kowarski A; Kohen F
Clin Chem; 1989 Jun; 35(6):913-7. PubMed ID: 2659222
[TBL] [Abstract][Full Text] [Related]
13. Assay-dependent results of immunoassayable spontaneous 24-hour growth hormone secretion in short children.
Granada ML; Sanmartí A; Lucas A; Salinas I; Carrascosa A; Foz M; Audí L
Acta Paediatr Scand Suppl; 1990; 370():63-70; discussion 71. PubMed ID: 2260460
[TBL] [Abstract][Full Text] [Related]
14. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies.
Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS
J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein.
Jansson C; Boguszewski C; Rosberg S; Carlsson L; Albertsson-Wikland K
Clin Chem; 1997 Jun; 43(6 Pt 1):950-6. PubMed ID: 9191545
[TBL] [Abstract][Full Text] [Related]
17. [Serum human growth hormone assay. Comparison of six assay kits].
Chabert-Orsini V; Simonin G; Brue T; Conte-Devolx B; Carayon P
Ann Endocrinol (Paris); 1992; 53(4):153-7. PubMed ID: 1305801
[TBL] [Abstract][Full Text] [Related]
18. Development of an in-house radioimmunoassay for human growth hormone.
Wan Nazaimoon WM; Satgunasingam N; Khalid B
Malays J Pathol; 1990 Jun; 12(1):13-20. PubMed ID: 2090885
[TBL] [Abstract][Full Text] [Related]
19. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
Rose DP; Berke B; Cohen LA
Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
[TBL] [Abstract][Full Text] [Related]
20. Variable estimates of serum growth hormone concentrations by different radioassay systems.
Reiter EO; Morris AH; MacGillivray MH; Weber D
J Clin Endocrinol Metab; 1988 Jan; 66(1):68-71. PubMed ID: 3335610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
